Robert S. Negrin

发表

Assays to determine hematopoietic stem cell content in blood or marrow grafts.

C. Verfaillie, J. Persio, R. Negrin, 1999, Cytotherapy.

Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia.

A. Nademanee, J. Niland, M. Amylon, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

sequestration and deletion of anti-donor T cells hematopoietic chimerism under mild conditioning : lymph-node T cells promote + third-party central-memory CD 8 − Murine anti

S. Reich-Zeliger, E. Ophir, D. Hagin, 2012 .

Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice.

R. Negrin, P. Chang, C. Hoyle, 1998, Blood.

A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation.

J. Vose, A. Nademanee, J. Fay, 1998, Blood.

The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Multiple Myeloma : An Evidenced-Based Review

R. Kyle, J. Wingard, P. McCarthy, 2022 .

Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms.

E. Meyer, R. Armstrong, R. Lowsky, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.

J. Vose, A. Nademanee, J. Dipersio, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes.

P. Greenberg, E. Liu, R. Negrin, 1994, Leukemia.

CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results.

B. Sahaf, L. Muffly, S. Sidana, 2024, Leukemia.

Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells.

R. Negrin, S. Reddy, S. Strober, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation.

V. Sundaram, D. Miklos, Lingyao Yang, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma

B. Sahaf, S. Sidana, J. Shizuru, 2024, Journal for immunotherapy of cancer.